Sun Pharmaceuticals Reports Strong Q3 FY24-25 Results with Record Profit and Sales Metrics
Sun Pharmaceuticals Industries has announced its financial results for the third quarter of FY24-25, reporting a Profit After Tax of Rs 3,168.72 crore, the highest in five quarters. Net sales reached Rs 13,675.46 crore, while Operating Profit stood at Rs 4,009.02 crore, indicating strong operational performance.
Sun Pharmaceuticals Industries has reported its financial results for the third quarter of FY24-25, showcasing a notable performance in various metrics. The company achieved a Profit After Tax (PAT) of Rs 3,168.72 crore, marking the highest figure recorded in the last five quarters, with a consistent upward trend observed in each quarter during this period. Net sales also reached a peak of Rs 13,675.46 crore, reflecting a strong trajectory in the near term. Additionally, the Operating Profit (PBDIT) stood at Rs 4,009.02 crore, again the highest in the last five quarters, indicating a favorable operational environment. Profit Before Tax less Other Income (PBT) was reported at Rs 3,326.95 crore, also the highest in the same timeframe, further supporting the positive trends in profitability.
Despite these strong financial indicators, the evaluation changes have led to a revision in its score, which has adjusted to 11 from 16 over the past three months. This reflects a shift in assessment amidst the backdrop of the company's performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
